Mutation of the LEPR Gene at Reunion Island: Involvement in Pediatric Obesity
GREOL
1 other identifier
observational
250
0 countries
N/A
Brief Summary
The objective of this study is to estimate the proportion of the recurrent deletion Δ6-8 of the LEPR gene in the homozygous and heterozygous state in pediatric cases with severe and early ( before the age of 6) obesity (BMI ≥ IOTF-30) on Reunion Island.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2020
CompletedFirst Posted
Study publicly available on registry
April 1, 2020
CompletedStudy Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedJanuary 27, 2021
January 1, 2021
1.3 years
March 30, 2020
January 26, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of the Δ6-8 deletion of the LEPR gene in paediatric population
Presence of the deletion of the LEPR gene
at inclusion
Secondary Outcomes (1)
Proportion of the Δ6-8 deletion of the LEPR gene in adult family members
6 months after inclusion of the paediatric population
Study Arms (2)
Pediatric population
Children between 3 to 18 years old with severe (BMI\> IOTF-30) and early (before the age of 6) obesity. A Saliva sample for screening of the deletion Δ6-8 of LEPR gene will be performed for each child.
Adult member family
The screening of the same deletion according the same procedure will be proposed to the adult family member if the child presents the deletion Δ6-8 of LEPR gene.
Eligibility Criteria
Children between 3 to 18 years old with severe obesity (BMI\>30) and adult family members.
You may qualify if:
- patient with early severe and non syndromic obesity (BMI\> IOTC-30) (before 6 years old)
- adult family members with deletion of LEPR gene
- informed consent form signed by participants or parents
- affiliation to social security scheme
You may not qualify if:
- patient with syndromic obesity
- patient Under guardianship or Under judicial protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Biospecimen
saliva sample
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul GUEGUEN, MD
CHU de La Réunion
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 30, 2020
First Posted
April 1, 2020
Study Start
March 1, 2021
Primary Completion
June 1, 2022
Study Completion
December 1, 2022
Last Updated
January 27, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share